ZEUS System (Zio Watch) vs Reveal LINQ Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by iRhythm Technologies, Inc.
VS

AI Verdict

The ZEUS System offers a non-invasive, wearable solution for continuous cardiac monitoring up to 14 days, focusing on detailed arrhythmia detection and characterization. In contrast, the Reveal LINQ Insertable Cardiac Monitor provides long-term, continuous subcutaneous ECG monitoring for up to 4.5 years via an implantable device, with its AI specifically designed to reduce false alerts. The choice between them depends on the required monitoring duration and the patient's willingness for an invasive procedure versus a wearable device.

Choose ZEUS System (Zio Watch) if…

Choose the ZEUS System (Zio Watch) if you require a non-invasive, wearable solution for continuous cardiac monitoring over a defined period of up to 14 days. This tool is ideal for patients experiencing intermittent symptoms where a shorter-term diagnostic window is sufficient to detect and characterize Atrial Fibrillation (AFib) and other arrhythmias, with the added benefit of patient symptom logging.

View ZEUS System (Zio Watch) →

Choose Reveal LINQ Insertable Cardiac Monitor if…

Choose the Reveal LINQ Insertable Cardiac Monitor if your patient requires very long-term, continuous cardiac monitoring, potentially for several years, due to highly infrequent or sporadic symptoms like unexplained syncope or suspected AFib. This implantable device offers a 4.5-year battery life and utilizes advanced AI to significantly reduce false alerts, providing sustained, accurate surveillance.

View Reveal LINQ Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature ZEUS System (Zio Watch) Reveal LINQ Insertable Cardiac Monitor
Pricing Contact vendor Contact vendor
Deployment Cloud-based system with a wearable device Implantable device with data transmitted to a cloud-based platform (CareLink™ network) via patient smartphone app or home communicator.
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ZEUS System (Zio Watch)

The ZEUS System (Zio Watch) is a non-invasive wearable device, which generally offers easier application and removal for patients compared to an implantable device. Its MyZio patient app further enhances usability by providing interactive features such as symptom logging, educational content, and reminders, promoting greater patient engagement and self-management.

Clinical Value

Reveal LINQ Insertable Cardiac Monitor

The Reveal LINQ ICM offers significantly longer-term monitoring with a 4.5-year battery longevity, which is crucial for detecting infrequent arrhythmias over extended periods. Its AccuRhythmu2122 AI algorithms are specifically designed to reduce false alerts, enhancing diagnostic yield and reducing clinician burden, thus providing superior long-term diagnostic accuracy.

Pricing & Value

Tie

Both tools require direct contact with the vendor for pricing information, and neither provides publicly disclosed details or comparative cost-effectiveness studies. Without specific pricing data, it is impossible to determine which tool offers better value.

Enterprise Readiness

Tie

Both tools are FDA-cleared, HIPAA compliant, and offer Business Associate Agreements (BAAs), demonstrating strong foundational enterprise readiness. Both also utilize cloud-based platforms for data management and clinician access, meeting core requirements for integration into healthcare systems. Tool B's remote programming is a valuable feature, but does not universally make it more enterprise-ready without further context.

Innovation

Reveal LINQ Insertable Cardiac Monitor

While both leverage AI, Tool B's AccuRhythmu2122 AI algorithms, which use deep learning to substantially reduce false positive alerts in an implantable cardiac monitor, represent a more impactful innovation. This directly addresses a critical challenge in long-term monitoring by improving diagnostic accuracy and reducing unnecessary clinical interventions.

Support & Docs

Reveal LINQ Insertable Cardiac Monitor

Medtronic (Tool B) provides a broader and more structured array of support channels, including dedicated patient service specialists and technical support lines with specified hours, along with comprehensive patient education resources like brochures, setup guides, and videos. It also offers detailed clinician manuals and specialized monitoring services.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature ZEUS System (Zio Watch) Reveal LINQ Insertable Cardiac Monitor
Name ZEUS System (Zio Watch) Reveal LINQ Insertable Cardiac Monitor
Company iRhythm Technologies Medtronic
Description iRhythm Technologies' ZEUS System (Zio Watch) is an FDA-cleared, AI-powered wearable for long-term continuous cardiac monitoring, specifically designed to detect and characterize Atrial Fibrillation (AFib) and other cardiac arrhythmias, providing actionable insights for physicians. The Medtronic LINQ IIu2122 Insertable Cardiac Monitor (ICM) with AccuRhythmu2122 AI algorithms provides long-term, accurate heart monitoring by using deep learning AI to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation and syncope.
Categories Cardiology AI, Wearables & Remote Monitoring (RPM) Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Family Medicine, Internal Medicine Cardiology, Pediatrics
Key Features (Monitoring Duration) Long-term continuous monitoring for up to 14 days 4.5-year battery longevity (nominal settings), Continuous, long-term subcutaneous ECG monitoring
Key Features (AI Capabilities) AI-powered algorithm (ZEUS System) for advanced arrhythmia detection and analysis AccuRhythmu2122 AI algorithms for reduced false alerts (AF and Pause)
Key Features (Patient Interface) MyZiou00ae patient app for digital symptom logging, educational content, and reminders MyCareLink Heartu2122 mobile app for patient data transmission, MyCareLink Relayu2122 home communicator for data transmission
Key Features (Reporting/Physician Interface) Clinically actionable reports with high physician agreement (99%), ZioSuiteu00ae portal and provider mobile app for report interpretation and patient management Enhanced ECG experience for clinical adjudication, Remote programming capabilities

Videos

Demos, reviews, and walkthroughs featuring ZEUS System (Zio Watch) and Reveal LINQ Insertable Cardiac Monitor.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The ZEUS System utilizes a wearable biosensor (Zio Watch) for continuous ECG and PPG data collection. In contrast, the Reveal LINQ Insertable Cardiac Monitor is an implantable device that provides continuous, long-term subcutaneous ECG monitoring.
The ZEUS System offers long-term continuous monitoring for up to 14 days. The Reveal LINQ ICM provides significantly longer monitoring with a 4.5-year battery longevity under nominal settings.
The ZEUS System is specifically designed to detect and characterize Atrial Fibrillation (AFib) and other cardiac arrhythmias. The Reveal LINQ ICM, with its AccuRhythm AI algorithms, enhances diagnostic yield for conditions like atrial fibrillation and syncope by reducing false alerts.
The ZEUS System employs an AI-powered algorithm for advanced arrhythmia detection and analysis, providing actionable insights. The Reveal LINQ ICM features AccuRhythm AI algorithms specifically designed to reduce false alerts for AF and Pause, thereby enhancing diagnostic accuracy.
For the ZEUS System, patients use the MyZio app for digital symptom logging, educational content, and reminders. The Reveal LINQ ICM transmits data to a cloud-based platform via the MyCareLink Heart mobile app or the MyCareLink Relay home communicator.
The ZEUS System provides clinically actionable reports with high physician agreement (99%). The Reveal LINQ ICM offers MRI compatibility (at u2264 3T with no post-insertion waiting) and remote programming capabilities.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.